Pharmacist Mobile App Intervention in Pediatric Inpatient

NCT07254741 | Completed

• 1 other identifier: (FMBSUREC/03102023/Tony)
• Study Type: interventional
• Target: 2,000
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to learn whether a clinical pharmacist-led medication review, supported by medical mobile applications, can improve the safety and quality of care for hospitalized children. The study compares usual care with enhanced pharmacist involvement to understand whether this approach reduces medication-related problems and supports better clinical outcomes. The main questions this study aims to answer are: Does the pharmacist-led review help identify and prevent medication issues in pediatric inpatients? Can this intervention improve the overall quality of care during hospitalization? Does the use of mobile medical applications assist pharmacists in making safer medication decisions? Participants will: Receive either routine care or routine care plus daily medication review by a clinical pharmacist Have their medications assessed regularly to identify potential problems Be followed during their hospital stay to observe clinical outcomes

Conditions

Medication Safety in Pediatric Inpatients

Outcome Measures

Primary Outcomes (1)

• Medication Errors Identified

  Number of medication errors detected during routine review of inpatient medication orders, including prescribing, dosing, frequency, and administration-related issues.

  From admission to hospital discharge (an average of 3-7 days)

Study Arms (2)

Pharmacist-Led Medication Review

EXPERIMENTAL

Behavioral: Pharmacist-Led Medication Review

Usual Care

NO INTERVENTION

Interventions

Pharmacist-Led Medication Review BEHAVIORAL

Daily medication review conducted by a clinical pharmacist using mobile medical applications to identify potential medication-related problems and support safer prescribing decisions for hospitalized pediatric patients.

Pharmacist-Led Medication Review

Eligibility Criteria

• Age: 2 Years - 15 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Age between 2 and 15 years
• Admitted to the pediatric general inpatient ward
• Prescribed three or more medications during the hospital stay

You may not qualify if:

• Length of hospital stay less than 48 hours
• Admission to the pediatric intensive care unit (PICU)
• Estimated life expectancy less than 24 hours

Sponsors & Collaborators

• Beni-Suef University: lead

Study Sites (1)

Clinical Research Coordination Unit

Cairo, Egypt

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Clinical Pharmacist and Principal Investigator

Study Record Dates

• First Submitted: November 18, 2025
• First Posted: November 28, 2025
• Study Start: March 12, 2024
• Primary Completion: September 12, 2024
• Study Completion: September 12, 2024
• Last Updated: November 28, 2025

Record last verified: 2025-11

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)